$95M raised by Taysha for clinical trials of four new gene therapies
FierceBiotech - 05-Aug-2020Company has gathered support from investors to quickly lead therapies to clinic then market
RA Session II
President, CEO & Founder at Taysha Gene Therapies
Specialties: Biopharmaceuticals, M&A, Licensing, Valuation, Strategic Planning, and Pricing
R A Session
Board Member, Lung Therapeutics Inc
CURRENT POSITION
TENURE AT CURRENT POSITION
PREVIOUS POSITION
EDUCATION
BOARD MEMBERSHIPS
INDUSTRY
Visit website: https://www.bloomberg.com/profile/person/20139014
See also
Details last updated 12-Aug-2020
RA Session II News
